Aperam S.A. (VIE:APAM)
Austria · Delayed Price · Currency is EUR | Market Cap | 2.71B +19.1% |
| Revenue (ttm) | 6.03B -3.9% |
| Net Income | 127.00M -33.9% |
| EPS | 1.75 -33.4% |
| Shares Out | n/a |
| PE Ratio | 21.31 |
| Forward PE | 10.77 |
| Dividend | 1.70 (4.58%) |
| Ex-Dividend Date | Nov 13, 2026 |
| Volume | 55 |
| Open | 37.88 |
| Previous Close | 39.24 |
| Day's Range | 37.00 - 37.88 |
| 52-Week Range | 29.58 - 53.15 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About Aperam
Aperam S.A., together with its subsidiaries, produces and sells stainless steel and alloy products worldwide. The company operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel, flat stainless and electrical steel, and special carbon products. It also produces specialty grades alloys and specialties. In addition, the company engages in tubes business, as well as provision of value added and customized steel solutions. Fur... [Read more]
Financial Performance
In 2025, Aperam's revenue was 6.08 billion, a decrease of -2.80% compared to the previous year's 6.26 billion. Earnings were 9.00 million, a decrease of -96.10%.
Financial StatementsNews
3 Dividend-Paying ADRs to Consider for Portfolio Diversification
Aperam, ASX Limited, and Grupo Cibest offer three very different ways to diversify beyond U.S. equities while collecting dividend yields above 3%.
Aperam price target raised to EUR 66 from EUR 65 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Aperam (APEMY) to EUR 66 from EUR 65 and keeps a Buy rating on the shares.
Aperam upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Dominic O’Kane upgraded Aperam (APEMY) to Overweight from Neutral with a price target of EUR 57, up from EUR 46.10. The firm sees the company benefiting from an…
Aperam Earnings Call Transcript: Q2 2026
Q2 2026 saw robust EBITDA despite market headwinds, with margin gains in Europe from trade reforms and strong contributions from non-European segments. Outlook remains cautious due to weak demand, but investments and innovation support future growth.
Aperam Slides: Q2 2026
Aperam has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Aperam Earnings release: Q2 2026
Aperam released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Aperam Quarterly report: Q2 2026
Aperam has published its Q2 2026 quarterly earnings report on July 30, 2026.
Aperam Earnings Call Transcript: Q2 2026
Q2 2026 delivered the strongest results in four years, with EBITDA up 77% sequentially and all segments contributing to growth. Strategic transformation, disciplined capital allocation, and robust cash generation underpin confidence in long-term targets despite macro headwinds.
Aperam Earnings release: Q2 2026
Aperam released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Aperam Slides: Q2 2026
Aperam has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Aperam Quarterly report: Q2 2026
Aperam has published its Q2 2026 quarterly earnings report on July 30, 2026.
Aperam price target raised to EUR 46.10 from EUR 42.70 at JPMorgan
JPMorgan analyst Dominic O’Kane raised the firm’s price target on Aperam (APEMY) to EUR 46.10 from EUR 42.70 and keeps a Neutral rating on the shares.
Aperam downgraded to Underperform from Neutral at BNP Paribas
BNP Paribas analyst Tristan Gresser downgraded Aperam (APEMY) to Underperform from Neutral with a price target of EUR 38, up from EUR 36.
Aperam downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Aperam (APEMY) to Equal Weight from Overweight with a price target of EUR 52, up from EUR 48. While the European stainless structural reset remains intact, supported…
Aperam price target raised to EUR 50 from EUR 42 at Citi
Citi raised the firm’s price target on Aperam (APEMY) to EUR 50 from EUR 42 and keeps a Neutral rating on the shares.
Aperam price target raised to EUR 63 from EUR 62 at Deutsche Bank
Deutsche Bank analyst Bastian Synagowitz raised the firm’s price target on Aperam (APEMY) to EUR 63 from EUR 62 and keeps a Buy rating on the shares. Published first on…
Aperam price target raised to EUR 42.70 from EUR 40.70 at JPMorgan
JPMorgan analyst Dominic O’Kane raised the firm’s price target on Aperam (APEMY) to EUR 42.70 from EUR 40.70 and keeps a Neutral rating on the shares.
Aperam Earnings Call Transcript: Q1 2026
European stainless operations saw improved utilization and margin expansion in Q1 2026, driven by reduced imports and restocking, while underlying demand remains weak. Guidance for 2028 EBITDA is EUR 700–800 million, with further upside from CapEx initiatives.
Aperam Earnings release: Q1 2026
Aperam released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Aperam Slides: Q1 2026
Aperam has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Aperam Earnings Call Transcript: Q1 2026
Q1 2026 delivered the best start in three years, with EBITDA up 34% quarter-on-quarter and all segments contributing. Outlook for Q2 is even stronger, driven by Brazil's seasonal uplift and European trade defense, while strategic investments and acquisitions support long-term growth.
Aperam Earnings release: Q1 2026
Aperam released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Aperam Slides: Q1 2026
Aperam has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Aperam price target raised to EUR 42 from EUR 37 at Citi
Citi analyst Krishan Agarwal raised the firm’s price target on Aperam (APEMY) to EUR 42 from EUR 37 and keeps a Neutral rating on the shares.
Aperam upgraded to Buy from Hold at Jefferies
Jefferies upgraded Aperam (APEMY) to Buy from Hold with a EUR 47 price target The firm note the derating in the stock following Iran war escalation, adding that given the…